Myofascial Release and Muscle Activity

Muscle Tone Abnormalities Clinical Trial

Official title:

Self Myofascial Release (SMR) and Bioelectrical Activity of Muscles

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04808024
• Other study ID #: SMR and muscle
• Status: Recruiting
• Phase: N/A
• Start date: January 4, 2021
• Est. completion date: May 2021

Study information

• Verified date: March 2021
• Source: Medical University of Silesia
• Contact: Piotr Michalik
• Phone: 694979743
• Email: piotrmichalikk[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to assess the impact of SMR intervention in the hamstring muscles on the activity of the biceps and gluteus muscles.

Description:

The study will cover 40 men, players of amateur football leagues, aged 18 - 40. The test will include the measurement of sEMG of the biceps and gluteal muscles during the exercise, followed by myofascial self-release (SMR). Muscle sEMG was re-measured immediately after roller therapy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: May 2021
• Est. primary completion date: April 21, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• signing informed consent to participate in the study

• age in the range of 18-40 years

Exclusion Criteria:

• people who had orthopedic injuries to the lower limbs and the lumbar-pelvic-iliac complex in the last year

• people who reported pain in the lower limbs and the lumbar-pelvic-iliac complex on the day of the examination

• people who underwent myofascial therapy in the last 6 weeks

• people with non-specific neuromuscular disorders

Related Conditions & MeSH terms

• Congenital Abnormalities
• Muscle Tone Abnormalities
• Self Myofascial Release

Intervention

Procedure:
• SelfMyofascial Release
Myofascial auto-release consisted of rolling the roller on a group of knee flexors for 3.5 minutes between the sciatic tumor and the knee joint in both directions, omitting the popliteal fossa. Before and after the intervention, sEMG of the biceps and gluteal muscles will be performed.

Locations

Country	Name	City	State
Poland	Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland	Katowice	Slaskie

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Silesia

Country where clinical trial is conducted

Poland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	1. Surface electromyography (sEMG) examination before SMR	The sEMG examination of the biceps and gluteus muscles will be performed using the MyoTrace 400 recorder by Noraxon USA Inc. with a sampling frequency of 1000 Hz, using the bipolar method, in accordance with SENIAM standards.The bioelectrical activity of the muscles will be tested during the squat.	Before the SMR intervention
Primary	Surface electromyography (sEMG) examination immediately after SMR	The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.	Immediately after the SMR intervention
Primary	Surface electromyography (sEMG) examination 5 minutes after SMR	The change in bioelectrical activity of the biceps and gluteus muscles will be performed. The bioelectrical activity of the muscles will be tested during the squat.	5 minutes after the SMR intervention